Resistance to targeted therapy in mantle cell lymphoma
Wednesday, June 14, 2017 - 17:21
in Health & Medicine
A team of cancer researchers have published research looking at the underlying mechanisms of resistance to the drug, Ibrutinib, which is used to treat patients with mantle cell lymphoma.